Workshops

Glenn Albrecht (Lynx Therapeutics, Inc.)
Luis Allegri (Motorola)
Christian Burks (Exelixis, Inc.)
Matthew Coleman (Lawrence Livermore National Laboratory)
Bruce Conklin (University of California at San Francisco)
Sam Eletr (Lynx Therapeutics, Inc.)
Richard Glynne (Phenomix)
Paul Heaney (Sequenom)
Michael Heller (Nanogen)
Stuart Kim (Stanford University)
Mel Kronick (Agilent Technologies)
Stephen Laderman (Agilent Technologies)
Deane Little (Hyseq)
Heiko Mueller (Monsanto / Pharmacia)
Krishnan Nandabalan (Genaissance Pharmaceuticals)
Stanley Nelson (UCLA)
Leena Peltonen (UCLA)
Alan Perelson (Los Alamos National Laboratory)
Martin Ringwald (Jackson Laboratory)
Carsten Rosenow (Affymetrix)
Alan Roter (Iconix Pharmaceuticals, Inc.)
Eric Schadt (Rosetta Inpharmatics, Inc.)
M. Michael Shabot (Cedars-Sinai Medical Center)
Ron Shamir (Tel-Aviv University, Israel)
Avi Shoshan (Compugen.com)
Richard Simon (National Cancer Institute)
Eugene Spier (Celera Genomics)
Jane Staunton (Massachusetts Institute of Technology,Whitehead Institute)
Charles Sugnet (University of California at Santa Cruz)
Rolf Swenson (Orchid Biosciences)
Rob Tibshirani (Stanford University)
Barbara Wold (California Institute of Technology)
Bin Yu (University of California at Berkeley)